Novonix Ltd
F:GC30
Novonix Ltd
F:GC30
Price:
0.482
EUR
-16.9%
Market Closed
Market Cap:
€59.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Novonix Ltd
F:GC30
|
AU |
|
WM Technology Inc
NASDAQ:MAPS
|
US |
|
K
|
KeyMed Biosciences Inc
F:64Z
|
CN |
|
D
|
Ducommun Inc
F:DUM
|
US |
|
P
|
PureTech Health PLC
OTC:PTCHF
|
US |
|
A
|
Aardvark Therapeutics Inc
NASDAQ:AARD
|
US |
|
C
|
China Petroleum & Chemical Corp
XHAM:CHU
|
CN |
|
Agora Inc
F:9AG1
|
CN |
|
H
|
HS Valve Co Ltd
KOSDAQ:039610
|
KR |
|
W
|
WPP PLC
XMUN:0WP
|
UK |
|
SpyGlass Pharma Inc
NASDAQ:SGP
|
US |
|
Propel Holdings Inc
TSX:PRL
|
CA |
|
O
|
Orient Cement Ltd
BSE:535754
|
IN |
|
Sumber Tani Agung Resources Tbk PT
IDX:STAA
|
ID |
|
3
|
3 E Network Technology Group Ltd
NASDAQ:MASK
|
HK |
|
thyssenkrupp AG
F:TKA1
|
DE |
|
Coherent Corp
MIL:1COHR
|
US |
|
Lumax AutoTechnologies Ltd
BSE:532796
|
IN |
|
Bucher Industries AG
F:BUHA
|
CH |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GC30's stock price target?
Not Available
GC30 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Novonix Ltd?
Projected CAGR
776%
776%
Over the last 2 years, the compound annual growth rate for Revenue has been -16%. The projected CAGR for the next 2 years is 776%.
